Superficial radiotherapy for patients with basal cell carcinoma
نویسندگان
چکیده
منابع مشابه
Management of primary superficial basal cell carcinoma.
BACKGROUND Superficial basal cell carcinoma (SBCC) is a skin cancer commonly treated by general practitioners. Little is known about how GPs choose from the available treatment options. METHOD A cross sectional survey was conducted by self administered questionnaire. RESULTS Of 257 GPs surveyed, 107 responded (adjusted response rate 59%). Sixty-three percent reported treating more than two ...
متن کاملBasal cell carcinoma of the lower extremities
Background: Basal cell carcinoma (BCC), the most common form of skin cancer, usually occurs in the sun-exposed areas of the body like head and neck, yet is also seen in unexpected sites. Myriad studies have mentioned a lower limb BCC incidence rate of 1.5-13.5%.Methods: The present retrospective cross-sectional study was conducted on 650 BCC patients, who were referred to the dermatology tumor ...
متن کاملClinical and histopathologic findings of superficial basal cell carcinoma: A comparison with other basal cell carcinoma subtypes.
BACKGROUND Basal cell carcinoma (BCC) is the most common cancer in white populations. However, BCC is uncommon in Taiwan, and its subtype, superficial BCC (SBCC), is even less common. The characteristics of these 2 cancers in Taiwanese have never been analyzed before. Our purpose was to study the clinical and histopathologic features of SBCC in comparison with other BCC subtypes (OBCC). METHO...
متن کاملConcurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma.
IMPORTANCE Vismodegib is a targeted agent recently approved for treating patients who develop recurrent or locally advanced basal cell carcinoma (BCC), and will inevitably be integrated into existing therapy for advanced BCC as it becomes increasingly used. Improved understanding of how vismodegib interacts with other treatment modalities, including radiotherapy, would help optimize multidiscip...
متن کاملANGIOGENESIS ASSESSMENT IN BASAL CELL CARCINOMA
Basal cell carcinoma (BCC) is currently the most common cutaneous cancer found in humans. Although it generally shows a relatively benign course (BCCl), some cases show aggressive behavior (BCC2). Until recently, traditional histologic diagnostic criteria have failed to discriminate unequivocally between BCC 1 and BCC2. In this study we selected 50 cases of BCC and categorized them into tw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2003
ISSN: 0008-543X
DOI: 10.1002/cncr.11798